The Cystic Fibrosis Foundation is the world’s leader in the search for a cure for cystic fibrosis, a rare, fatal disease affecting 70k worldwide. We are a nonprofit, donor-supported organization that has raised and invested hundreds of millions of dollars to help develop cystic fibrosis therapies that have changed the lives of people with this disease. Nearly every CF medicine available today was made possible because of Foundation support, including Kalydeco, a medicine that Forbes magazine called “The Most Important Drug of 2012.” The Foundation's pioneering business model has been featured in two Harvard Business School case studies and by publications such as Forbes, The Wall Street Journal, The New Yorker, and Bloomberg Businessweek. Through the Foundation’s efforts, the life expectancy of a child with CF has doubled in the last 30 years. Based in Bethesda, Md., the Foundation created, funds and accredits a national network of cystic fibrosis care centers that have been recognized by the National Institutes of Health as a model of care for a chronic disease. The Cystic Fibrosis Foundation is one of the most efficient organizations of its kind and is an accredited charity of the Better Business Bureau's Wise Giving Alliance.